Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
AbbVie crafts $1.6B deal with molecular glue biotech Neomorph
Neomorph is building out its supply of pharma partnerships, stamping down an option-to-license pact with AbbVie centered on molecular glue degraders.
Gabrielle Masson
Jan 23, 2025 9:58am
Exicure buys GPCR's US unit and clinical-stage blood cancer drug
Jan 23, 2025 5:01am
Novo inks IMMvention deal to orchestrate attack on sickle cell
Jan 22, 2025 9:41am
ArriVent pays Lepu $47M for GI-focused preclinical ADC
Jan 22, 2025 7:15am
RTW-built biotech's $520M deal for InnoCare, Keymed bispecific
Jan 21, 2025 4:32am
Serina sheds AgeX assets to become debt-free
Jan 16, 2025 4:00am
